Use of the Quantra QPlus Sytem in Cardiac Surgery

NCT05501730 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2022-08-15

No results posted yet for this study

Summary

Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.

Conditions

Interventions

DIAGNOSTIC_TEST

Quantra QPlus System

Coagulation monitoring system

Sponsors & Collaborators

  • HemoSonics LLC

    lead INDUSTRY

Principal Investigators

  • Pierre Tibi, MD · Yavapai Regional Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2021-11-21
Completion
2021-12-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05501730 on ClinicalTrials.gov